The alternating current polarographic behavior and determination of lansoprazole and omeprazole in dosage forms and biological fluids

1999, 1196, 1204 Ozaltin, 1999, Determination of lansoprazole in pharmaceutical dosage forms by two different spectroscopic methods, J Pharm Biomed Anal, 20, 599, 10.1016/S0731-7085(99)00061-8 Wahbi, 2002, Spectrophotometric determination of omeprazole, lansoprazole and pantoprazole in pharmaceutical formulations, J Pharm Biomed Anal, 30, 1133, 10.1016/S0731-7085(02)00464-8 Tivesten, 1999, Non aqueous capillary electrophoresis for the analysis of labile pharmaceutical compounds, Chromatographia, 49, S7, 10.1007/BF02468970 Ekpe, 1999, Effect of various salts on the stability of lansoprazole, omeprazole and pantoprazole as determined by high-performance liquid chromatography, Drug Dev Ind Pharm, 25, 1057, 10.1081/DDC-100102270 Montanari, 2006, The role of molecular interaction fields on enantioselective and nonselective separation of chiral sulfoxides, J Chromatogr A, 1121, 64, 10.1016/j.chroma.2006.04.072 Uno, 2005, Determination of lansoprazole and two of its metabolites by liquid–liquid extraction and automated column-switching high-performance liquid chromatography: application to measuring CYP2C19 Activity, J Chromatogr B Analyt Technol Biomed Life Sci, 816, 309, 10.1016/j.jchromb.2004.11.052 El-Zehauri, 2001, Saudi Pharm J, 9, 99 Radi, 2003, Anodic voltammetric assay of lansoprazole and omeprazole on a carbon paste electrode, J Pharm Biomed Anal, 31, 1007, 10.1016/S0731-7085(02)00707-0 Belal, 2004, Anodic polarographic determination of lansoprazole and omeprazole in pure form and in pharmaceutical dosage forms, J Food and Drug Anal, 12, 102 Ozaltin, 1997, Determination of omeprazole in pharmaceuticals by derivative spectroscopy, J Pharm Biomed Anal, 16, 337, 10.1016/S0731-7085(97)00046-0 karljikovic-Rajic, 2003, Frst order UV-derivative spectrophotometry in the analysis of omeprazole and pantoprazole sodium salt and corresponding impurities, J Pharm Biomed Anal, 32, 1019, 10.1016/S0731-7085(03)00204-8 Salama, 2003, Validation of spectrophotometric determination of omeprazole and pantoprazole sodium via their metal chelates, J Pharm Biomed Anal, 33, 411, 10.1016/S0731-7085(03)00233-4 Altria, 1997, Validation capillary electrophoresis method for the analysis of a range of acidic drugs and excipients, J Pharm Biomed Anal, 15, 1091, 10.1016/S0731-7085(96)02000-6 Eberle, 1997, Chiral resolution of pantoprazole sodium and related sulfoxides by complex formation with bovine serum albumin in capillary electrophoresis, J Chromatogr, 759, 185, 10.1016/S0021-9673(96)00769-8 Ozaltin, 1994, Differential-pulse-polarographic determination of omeprazole in pharmaceutical preparations, Electroanalysis, 6, 799, 10.1002/elan.1140060915 Mcclean, 1994, Differential-pulse-polarographic study of the degradation of hydrogen ion/potassium ion ATPase inhibitors SkandF 95601 and omeprazole in acidic media and the subsequent reaction with thiols, Anal Chim Acta, 292, 81, 10.1016/0003-2670(94)00043-3 Oelschlaeger, 1998, Polarographic analysis of omeprazole formulations, Pharmazie, 53, 242 Qaisi, 2006, Acid decomposition of omeprazole in the absence of thiol: a differential pulse polarographic study at the Static Mercury Drop Electrode (SMDE), J Pharm Sci, 95, 384, 10.1002/jps.20546 Jia, 2006, Determination of omeprazole in rat plasma by high-performance liquid chromatography without solvent extraction, J Chromatogr B Analyt Technol Biomed Life Sci, 637, 112, 10.1016/j.jchromb.2006.04.007 Hofmann, 2006, Sensitive quantification of omeprazole and its metabolites in human plasma by liquid chromatography-mass spectrometry, J Chromatogr B Analyt Technol Biomed Life Sci, 831, 85, 10.1016/j.jchromb.2005.11.036 Dogrukol, 1998, TLC densitometric determination of omeprazole in pharmaceutical preparations, Pharmazie, 53, 272 Al-Omar, 2005, Voltammetric study of danazol and its determination in capsules and spiked biological fluids, J Pharm Biomed Anal, 37, 199, 10.1016/j.jpba.2004.10.011 Heyrovsky, 1968, 163, 179 “Guidance for industry bioanalytical method validation, US Department of Health and Human Services, Food and Drug Administration”, Center for Drug Evaluation and Research, Rockville, MD, May. 2001 http://www.fda.gov/eder/guidance/4252fnl.pdf (accessed September1, 2004). Miller, 2005, 256 Moffat, 2004, 1163 Koch-Weser J, Sellers EM. Binding of drug to serum albumin, N Engl J Med, 1976; 294: 311–316; 526–531. DellaGreca, 2006, Degradation of lansoprazole and omeprazole in the aquatic enviroment, Chemosphere, 63, 1087, 10.1016/j.chemosphere.2005.09.003